Critical discovery in Parkinson's disease: Harmful proteins block the brain's waste disposal system

A new biological mechanism has been elucidated in the world of neurology regarding the progression of Parkinson's disease, which damages the central nervous system and limits mobility. Until now, it was thought that the "alpha-synuclein" (α-syn) protein associated with the disease accumulated only within brain cells, leading to neuron death. However, a new study published in the respected medical journal Journal of Experimental Medicine proved that these toxic protein clusters sabotage the waste disposal system by blocking the lymphatic vessels at the outer borders of the brain.

Comprehensive examinations of dura mater and cerebrospinal fluid (CSF) samples taken from Parkinson's patients and laboratory models revealed how the disease accelerates in a vicious circle.

LYMPHATIC VESSELS ON THE OUTER WALL OF THE BRAIN GET INFLAMMED

A healthy human brain evacuates biological wastes resulting from cellular activities from the skull to the lymph nodes in the neck through meningeal lymphatic vessels in the brain membrane. The research team found that misfolded alpha-synuclein proteins, which cluster in the brain membranes of Parkinson's patients, accumulate precisely adjacent to these drainage vessels.

In experiments, it was determined that the waste flow came to a halt in tissues exposed to these toxic proteins in the cerebrospinal fluid. Tests conducted with human lymphatic cells in the laboratory showed that protein clusters weakened the intercellular connections in the vessel wall and slowed down the formation of new vessels.

IMMUNE CELLS DISRUPT THE VASCULAR STRUCTURE BY RELEASING TNF SIGNAL

Researchers also solved the molecular code of the blockage in the drainage system with the RNA and genetic analyzes they conducted. It was determined that protein deposits at the borders of the brain activate the Tnf gene by stimulating the immune cells (macrophages) in the area.

The inflammatory TNF protein produced in excessive amounts by the activated gene caused structural damage and inflammation in the lymphatic vessels, completely disabling the brain's cleaning mechanism.

IT HAS BEEN UNDERSTOOD WHY CURRENT DRUG TREATMENTS ARE INSUFFICIENT

The findings also explain why the experimental Parkinson's treatments developed today have not achieved the expected success. Scientists emphasize that current drugs focus only on breaking down toxic proteins within the brain tissue, but as long as the brain's external drainage channels remain blocked, the broken down waste cannot be removed from the skull.

Experts state that repairing the brain's lymphatic drainage system and stopping inflammation will be a vital goal in future Parkinson's treatments, as well as preventing toxic protein accumulation.